A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses

NCT05310032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: HSG4112
DRUG: Placebo

Sponsor

Glaceum

Collaborators

[object Object]